Watch a short video to learn more about our approach.
The Problem
TBI is a Global Problem. Mild TBI, more commonly called concussion, is underdiagnosed and invisible, so often missed.
Over 50 million people suffer a TBI worldwide annually resulting in an estimated medical costs of $76.5 billion.
“Since our Brain defines who we are, the consequences of a brain injury can affect all aspects of our lives.”
The Solution
At BRAINBox Solutions, we are developing an AI-Enabled Comprehensive Multi-Modality TBI product to deliver a single score to aid in diagnosis of mild TBI and to provide a prognostic view of a patient’s likelihood of post-concussive symptoms.
How It Works
Using a small sample of blood, the BRAINBox point of care device will run a panel of TBI-associated blood-based biomarkers.
The BRAINBox panel is analyzed in tandem with a neurocognitive assessment on a tablet or mobile device.
These biological and functional measurements are utilized by the BRAINBox algorithm to provide a simple, and easy to read, BRAINBox TBI score.
BRAINBox Solutions is currently enrolling subjects in the HeadSMART II Study, following Breakthrough Designation by the FDA for providing the first product to deliver a single score, used as an Aid to Diagnosis and to provide a Prognosis report of a patient’s likelihood of postinjury symptom occurrence.
Learn more by visiting ClinicalTrials.gov and using the following identifier: NCT04423198.